Enzymatic Production of Ribavirin [PDF]
Agricultural and Biological Chemistry, 1988 Criblage de 400 souches bacteriennes afin de selectionner des bacteries capables de produire du ribose (phosphate-1) a partir de l'inosine ou de la ribavirine (antiviral) a partir du ribose (phosphate-1), grâce a leur activite purine-nucleoside phosphorylase.
Hideyuki Shirae +2 more
openalex +4 more sources
Efficacy and Safety of Adding Ribavirin to Sofosbuvir-Based Direct-Acting Antivirals (DAAs) in Re-Treating Non-Genotype 1 Hepatitis C—A Systematic Review and Meta-Analysis [PDF]
DiseasesBackground: There is still debate whether ribavirin should be added to direct-acting antivirals (DAAs) for the management of treatment-experienced individuals with non-genotype-1 hepatitis C.
Shahd Hamran +10 more
doaj +2 more sources
Baseline MELD score predicts hepatic decompensation during antiviral therapy in patients with chronic hepatitis C and advanced cirrhosis [PDF]
, 2013 Background and Aims: In patients with advanced liver cirrhosis due to chronic hepatitis C virus (HCV) infection antiviral therapy with peginterferon and ribavirin is feasible in selected cases only due to potentially life-threatening side effects ...
Dultz, Georg +11 more
core +15 more sources
Update on Hepatitis E Virus Infection 2025: Insights From an International Symposium. [PDF]
Liver IntABSTRACT Background and Aims The second Hepatitis E Symposium was held as an integral part of the International DFG/DZIF Joint Meeting on Viral Infections of the Liver and the Heart in Berlin. The symposium aimed to provide a comprehensive exploration of hepatitis E virus (HEV) research and bring together clinicians, basic scientists, public health ...
Buchardt L +11 more
europepmc +2 more sources
Frontiers in Public Health, 2021 Background: Intravenous (IV) ribavirin is not approved in US and European Union, but it is authorized in China. Significant teratogenic and embryocidal effects of ribavirin have been found in almost all animal studies, it is critical to investigate the ...
Hailong Li +5 more
doaj +1 more source
High Efficiency and Safety of Hepatitis C Treatment Among People Who Inject Drugs in Vietnam. [PDF]
J Viral HepatABSTRACT People who inject drugs (PWID) are highly affected by hepatitis C (HCV) worldwide, particularly in low‐ and middle‐income countries (LMICs), where access to addiction services is often limited. Reducing the burden of HCV, as promoted by WHO, requires effective interventions in this high‐risk population.
Laureillard D +21 more
europepmc +2 more sources
Ribavirin enhances the action of interferon-α against hepatitis C virus by promoting the p53 activity through the ERK1/2 pathway. [PDF]
PLoS ONE, 2012 Background/aimsRibavirin significantly enhances the antiviral response of interferon-α (IFN-α) against Hepatitis C virus (HCV), but the underlying mechanisms remain poorly understood. Recently, p53 has been identified as an important factor involving the
Wei-Liang Liu +8 more
doaj +1 more source
Ribavirin-induced anemia in hepatitis C virus patients undergoing combination therapy. [PDF]
PLoS Computational Biology, 2011 The current standard of care for hepatitis C virus (HCV) infection - combination therapy with pegylated interferon and ribavirin - elicits sustained responses in only ∼50% of the patients treated.
Sheeja M Krishnan, Narendra M Dixit
doaj +1 more source
A randomized, placebo‐controlled study to evaluate safety and pharmacokinetics of inhaled ribavirin
Clinical and Translational Science, 2022 Ribavirin is an inosine monophosphate dehydrogenase inhibitor. Studies suggest ribavirin aerosol could be a safe and efficacious treatment option in the fight against coronaviruses. However, current treatment is long (12–18 h per day, 3–7 days), limiting
Peter Couroux +6 more
doaj +1 more source